ImproWise

Complex eClinical Solution for EDC/ERT/eCOA that significantly speeds up the start of clinical trials (up to 5 days), saves budget (up to 80% for monitoring), increases the capitalization and attractiveness of your company (noted by 89% of customers). Increases the knowledge and advancement of Data Management and Data Science professionals (noted by 96% of specialists). 94% of investigators like the usability of interfaces. An important part of Data Management 365 policy is to have strong internal competence in Clinical Data Management and Data Science. This allows our company not only to deeper understand the challenges that Data Managers face in their work and make the MainEDC™platform better using the online feedback but also to provide the transfer of technology and best practices to our Clients.

Medrio is on a mission to ease complexity in today’s hybrid, decentralized, and site-based clinical trials by delivering a flexible suite of eClinical technologies and services, including EDC, eCOA, ePRO, eConsent, Direct Data Capture, and Randomization and Trial Supply Management (RTSM). Trusted by CROs, sponsors, and sites across all therapeutic areas and trial phases from study startup and feasibility to post-market approval, we are industry-recognized for delivering eClinical software with intuitive interfaces and time-saving “drag and drop” configurations as well as high-touch customer engagement, onboarding, and support services. Medrio’s innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.